Alexandria Hammond

Stock Analyst

(n/a)
# 4,650
Out of 4,650 analysts
3
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Alexandria Hammond

Akero Therapeutics
Apr 22, 2024
Reinstates: Neutral
Price Target: $30
Current: $32.38
Upside: -7.35%
Madrigal Pharmaceuticals
Apr 22, 2024
Initiates: Underperform
Price Target: $150
Current: $339.04
Upside: -55.76%
89bio
Apr 22, 2024
Assumes: Buy
Price Target: $30
Current: $9.05
Upside: +231.49%